Skip to content
- Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer.
- Lee YJ, Kim HS, Rim JH, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT.
- BMC Cancer. 2020 Mar 4;20(1):185. doi: 10.1186/s12885-020-6688-8.
- Exceptional Response to Olaparib in a Patient With Recurrent Ovarian Cancer and an Entire BRCA1 Germline Gene Deletion.
- Randall M, Burgess K, Buckingham L, Usha L.
- J Natl Compr Canc Netw. 2020 Mar;18(3):223-228. doi: 10.6004/jnccn.2019.7378.
- Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
- Christenson ES, Jaffee E, Azad NS.
- Lancet Oncol. 2020 Mar;21(3):e135-e145. doi: 10.1016/S1470-2045(19)30795-8.